Volpara will showcase its suite of quantitative breast imaging tools, which allow for personalised measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening. VolparaEnterprise software delivers key performance indicators for hundreds of performance and quality metrics, including patient positioning, compression and equipment utilisation. The software provides continuous quality assurance and performance monitoring through dynamic, interactive dashboards. Volpara will also showcase its new VolparaEnterprise DDP software. The VolparaEnterprise Clinical Applications software package offers access to VolparaDensity, VolparaDose and VolparaPressure, in a Software as a Service (SaaS) subscription model. VolparaEnterprise Clinical Applications produces a Volpara Scorecard for every patient with the following data: • VolparaDensity, the most clinically validated 3D Density solution, helps radiologists assess breast density more objectively and better consider who might benefit from additional screening. • VolparaDose helps understand the X-ray dose, based on her specific breast density, to provide a personalised dose measure. • VolparaPressure helps evaluate the effectiveness of the mammogram and to better understand the patient experience. VolparaPressure helps monitor and optimise pressure during mammography exams, which is important to decrease the discomfort experienced by women and to optimise screening outcomes.